scholarly article | Q13442814 |
P2093 | author name string | Catherine Leimkuhler Grimes | |
Ching-Wen Hou | |||
Vishnu Mohanan | |||
Amy K Schaefer | |||
James E Melnyk | |||
P2860 | cites work | Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection | Q24292675 |
The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease | Q24296753 | ||
Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition | Q24306842 | ||
Quantification of protein half-lives in the budding yeast proteome | Q24674092 | ||
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease | Q28201834 | ||
A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system | Q33268810 | ||
Why are the hydroxy groups of partially protected N-acetylglucosamine derivatives such poor glycosyl acceptors, and what can be done about it? A comparative study of the reactivity of N-acetyl-, N-phthalimido-, and 2-azido-2-deoxy-glucosamine deriva | Q33423429 | ||
Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin | Q33699590 | ||
An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride | Q34005894 | ||
Deception point: peptidoglycan modification as a means of immune evasion | Q35612173 | ||
Chemoenzymatic synthesis of uridine diphosphate-GlcNAc and uridine diphosphate-GalNAc analogs for the preparation of unnatural glycosaminoglycans | Q35736952 | ||
Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP. | Q36080388 | ||
Proteasomal degradation of Nod2 protein mediates tolerance to bacterial cell wall components | Q36407841 | ||
Debugging how bacteria manipulate the immune response. | Q36739044 | ||
Structural variation in the glycan strands of bacterial peptidoglycan | Q37028275 | ||
Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide | Q37292790 | ||
Nod2 is required for the regulation of commensal microbiota in the intestine | Q37354181 | ||
NOD1 and NOD2 Signaling in Infection and Inflammation. | Q38060719 | ||
The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment | Q39303552 | ||
Synthesis of biologically active biotinylated muramyl dipeptides | Q39658629 | ||
Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells | Q40170522 | ||
Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding | Q40855596 | ||
Synthesis and immunoadjuvant activities of muramoyl-L-alanyl-D-isoglutamine and some carbohydrate analogs | Q42271581 | ||
Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity | Q42277949 | ||
Design and synthesis of novel cell wall inhibitors of Mycobacterium tuberculosis GlmM and GlmU. | Q42731628 | ||
Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan | Q45136861 | ||
Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus | Q45231397 | ||
Synthesis of a biologically active fluorescent muramyl dipeptide congener | Q46360933 | ||
A robust synthesis of N-glycolyl muramyl dipeptide via azidonitration/reduction. | Q51027831 | ||
The importance of ligands for G protein-coupled receptor stability. | Q53634312 | ||
Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives | Q53768109 | ||
Chemical modification of the C-6 substituent in the carbohydrate moiety of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP), and the immunoadjuvant activity. | Q53919364 | ||
A safe and facile route to imidazole-1-sulfonyl azide as a diazotransfer reagent | Q85653333 | ||
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 6987-6990 | |
P577 | publication date | 2015-06-02 | |
P1433 | published in | Journal of the American Chemical Society | Q898902 |
P1476 | title | Peptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2 | |
P478 | volume | 137 |
Q58780924 | Bacterial Strategies to Preserve Cell Wall Integrity Against Environmental Threats |
Q47973286 | Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70. |
Q42047981 | From bacterial killing to immune modulation: Recent insights into the functions of lysozyme |
Q48124216 | Membrane Association Dictates Ligand Specificity for the Innate Immune Receptor NOD2. |
Q33622000 | Metabolic labelling of the carbohydrate core in bacterial peptidoglycan and its applications |
Q54236491 | Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2. |
Q46269946 | NOD2 and bacterial recognition as therapeutic targets for Crohn's disease. |
Q38741155 | Neisseria gonorrhoeae Lytic Transglycosylases LtgA and LtgD Reduce Host Innate Immune Signaling through TLR2 and NOD2. |
Q52732929 | Peptidoglycan recognition by the innate immune system. |
Q38795438 | The effect of NOD2 on the microbiota in Crohn's disease |